Moreover, a study constructed a score based on alpha-fetoprotein and C-reactive protein to predict disease control rate and OS in immune checkpoints inhibitors (ICI)-treated patients with HCC (46). The gene discussed is AFP; the disease is hepatocellular carcinoma.